Troview
Intelligence
Intent
Services
Report Sectors
City Deep-Dive Healthcare RE Report ID: TRV-RD-300 Published June 2026

Singapore Healthcare REIT Market

TROVIEW INTELLIGENCE | Singapore Healthcare REIT Market | Q2 2026 TROVIEW INTELLIGENCE · COUNTRY INTELLIGENCE REPORT By REIT · By Property Type · By Geographic Distribution · By Tenant Covenant REIT Profiles: Parkway Life REIT (C2PU) · First REIT (AW9U) · Comparative Analysis · SGX Healthcare S-REIT Sector Parkway Life REIT, one of Asia's largest listed healthcare REITs, reported 9M 2025 gross revenue of SGD 117.3 mi...
Base Year Value
USD 4.86 Billion
Forecast Value (2035)
USD 10.32 Billion
CAGR
7.8%
Report ID
TRV-HC-010-CTR
Base Year
2025
Pages
240+
Purchase This Report
Standard License
PDF + Excel delivery
$7,500
Enterprise License
Unlimited users · Raw data export
$10,500
Purchase Now Request Preview Summary
TROVIEW INTELLIGENCE | Singapore Healthcare REIT Market | Q2 2026
TROVIEW INTELLIGENCE · COUNTRY INTELLIGENCE REPORT

By REIT · By Property Type · By Geographic Distribution · By Tenant Covenant

REIT Profiles: Parkway Life REIT (C2PU) · First REIT (AW9U) · Comparative Analysis · SGX Healthcare S-REIT Sector

Parkway Life REIT, one of Asia's largest listed healthcare REITs, reported 9M 2025 gross revenue of SGD 117.3 million up 8.2% year-on-year with distributable income of SGD 75.4 million up 10.4% year-on-year and a 9M 2025 DPU of 11.56 cents, maintained 17 consecutive years of DPU growth since its 2007 IPO, trades at approximately 1.68 times price-to-book with gearing at 35.8% and interest coverage ratio of 8.9x, with FY2026 aggregate rent from Singapore hospitals expected to increase 24.4% year-on-year from SGD 79.7 million to SGD 99.2 million following completion of the AEI at Mount Elizabeth Hospital as part of Project Renaissance, its SGD 2.57 billion portfolio comprising three Singapore private hospitals and 71 nursing homes across Japan and France, and the master lease for its three Singapore hospitals renewed for 20.4 years to December 2042 with guaranteed rent escalation while First REIT owns 32 healthcare properties valued at SGD 1.12 billion including 15 Indonesian hospitals, confirming Singapore as the primary listed healthcare REIT jurisdiction in Asia Pacific and the reference market for Asian institutional healthcare real estate investment.

Standard License: USD 6,500Enterprise License: USD 9,500

MARKET SYNOPSIS

The Singapore healthcare REIT market size was USD 4.86 Billion in 2025 and is expected to register a revenue CAGR of 7.8% during the forecast period, reaching USD 10.32 Billion by 2035. The 2025 market estimate is grounded in verified company revenues: Parkway Life REIT reported a portfolio value of SGD 2.57 billion comprising three private hospitals in Singapore and 71 nursing homes and care facilities across Japan and France as of September 2025, with 9M 2025 gross revenue of SGD 117.3 million up 8.2% year-on-year and distributable income of SGD 75.4 million up 10.4% year-on-year per Growbeansprout analysis citing Parkway Life REIT quarterly results; and First REIT held 32 healthcare properties valued at SGD 1.12 billion spanning Indonesia, Singapore, and Japan including 15 Indonesian hospitals. The market encompasses the total asset value and investible real estate market of Singapore-listed healthcare REITs and their underlying property portfolios, including the unlisted private healthcare real estate market in Singapore's primary care and specialist clinic segments. Market revenue growth is anchored in Singapore's position as Southeast Asia's premium private healthcare hub, the structural ageing demographics of Singapore's resident population and the regional patient base from across ASEAN that utilises Singapore's world-class private hospital network, and the unique structural characteristics of Singapore healthcare REITs including triple-net lease structures with IHH Healthcare-backed master leases, government rent reimbursement frameworks, and 20-to-25-year lease durations that provide the income security that defines Singapore healthcare REIT investment appeal. For instance, in FY2026, Parkway Life REIT, Singapore, expects aggregate rent payable from its three Singapore private hospitals Mount Elizabeth, Gleneagles, and Parkway East to increase 24.4% year-on-year from SGD 79.7 million to SGD 99.2 million, following the completion of the asset enhancement initiative at Mount Elizabeth Hospital as part of Project Renaissance, driving the most substantial single-year Singapore hospital rental uplift in the REIT's 17-year operating history per Growbeansprout analysis citing Parkway Life REIT FY2026 guidance. These are some of the key factors driving revenue growth of the market.

Parkway Life REIT has delivered uninterrupted recurring DPU growth in every year since its 2007 IPO, with DPU growing approximately 136% from an annualised DPU of 6.32 cents in 2007 to 14.92 cents in FY2024, making it one of the longest uninterrupted DPU growth streaks in the global REIT universe per Growbeansprout research. The master lease for Parkway Life REIT's three Singapore hospitals was renewed in 2021 for a 20.4-year term ending December 2042, with an option to renew for a further 10 years, providing guaranteed rent escalation of 2% to 3% annually until FY2025 followed by a CPI-linked formula from FY2026, and with Singapore representing 62.5% to 65% of total asset value per Parkway Life REIT quarterly reporting as of September 2025. The master lease is structured as a triple-net lease with the Singapore assets leased to Parkway Hospitals Singapore, a wholly owned subsidiary of IHH Healthcare Berhad, one of the world's largest healthcare groups, providing a tenant covenant that matches or exceeds any triple-net healthcare REIT tenant in the US or European markets. First REIT, Singapore, holds 32 healthcare properties valued at SGD 1.12 billion spanning 15 Indonesian hospitals, Singapore assets, and Japan properties, providing geographic diversification within the Southeast Asian healthcare real estate universe at a lower portfolio quality tier than Parkway Life REIT's premium Singapore hospital anchor per ProsperUs analysis. These are some of the key factors driving revenue growth of the market.

However, the Singapore healthcare REIT market faces structural constraints that temper the pace of asset value growth through the forecast period. Currency exchange rate risk is the primary earnings volatility source for Parkway Life REIT, with approximately 27% of earnings derived from Japan and 8% from France, exposing DPU to Japanese yen and euro fluctuations that the REIT partially hedges through JPY-denominated loan financing with the REIT having secured a seven-year JPY loan to refinance one-third of its 2026 maturities, extending weighted average debt term from 2.8 to 3.2 years per Growbeansprout Q3 2025 analysis. Iran-US geopolitical tensions and LNG price volatility through the Strait of Hormuz, as confirmed by IMF March 2026 analysis, affect Singapore healthcare REIT properties through their impact on Singapore's electricity costs, as Singapore's near-total reliance on LNG-fired electricity generation exposes the energy costs of 24-hour private hospital operations to international LNG spot price volatility that the IHH Healthcare master lease structure partly absorbs through triple-net pass-through of operating costs. The concentration of Parkway Life REIT's Singapore asset value in three private hospitals under a single master tenant Parkway Hospitals Singapore, a subsidiary of IHH Healthcare means that any material deterioration in IHH Healthcare's operating performance or financial position would simultaneously affect all three Singapore hospital assets, creating concentration risk that is mitigated but not eliminated by IHH's global scale and financial strength. These factors substantially limit Singapore healthcare REIT market growth over the forecast period.

Troview Analyst Perspective

Parkway Life REIT is one of the rarest things in the global REIT universe: a healthcare REIT that has grown its distribution to unitholders every single year since listing in 2007. Seventeen consecutive years. Through the global financial crisis. Through the pandemic. Through the 2022 interest rate cycle. Through the Japanese yen weakening to 30-year lows. That track record is not an accident. It is the output of a master lease structure that guarantees annual rent escalation from an IHH Healthcare-backed tenant, with the Singapore hospitals' 20.4-year lease running to December 2042 providing income visibility that no hotel, retail, or office REIT can match. The FY2026 rent uplift of 24.4% year-on-year following the Mount Elizabeth AEI completion is not a market cycle event. It is a contractually guaranteed step-up embedded in the lease terms. That combination a government-linked healthcare system backing the tenant, a 20-year lease with contractual escalation, a 17-year DPU growth track record, and a market cap that has compounded at exceptional rates is why international institutional investors view Parkway Life REIT as Asia's closest equivalent to the NHS-backed primary care REITs that US capital is targeting in the UK at premium valuations." Troview Intelligence Head of Singapore Healthcare REIT Research

SEGMENT INSIGHTS

By REIT
Parkway Life REIT (SGX: C2PU) is expected to account for a significantly large revenue share in the Singapore healthcare REIT market during the forecast period.Based on REIT, the Singapore healthcare REIT market is segmented between Parkway Life REIT and First REIT, together with the unlisted private healthcare real estate market. Parkway Life REIT accounts for the dominant share of Singapore healthcare REIT market value at SGD 2.57 billion in portfolio value as of September 2025, with Singapore representing 62.5% to 65% of total asset value through its three private hospitals Mount Elizabeth, Gleneagles, and Parkway East leased to Parkway Hospitals Singapore under a 20.4-year master lease to December 2042, and with Japan nursing homes and France nursing homes comprising the international growth components of the portfolio.First REIT, with 32 properties valued at SGD 1.12 billion, accounts for the smaller listed segment of the Singapore healthcare REIT market, with Indonesia representing the majority of its hospital property exposure across 15 Indonesian hospitals and with its strategic focus on diversifying into Japan nursing homes while reviewing potential asset restructuring in Indonesia, where the regulatory and operating environment for private hospital real estate presents higher risk than Singapore's IHH-anchored triple-net lease structure per ProsperUs analysis.
By Property Type
Private hospital real estate segment is expected to account for a significantly large revenue share in the Singapore healthcare REIT market during the forecast period.Based on property type, the Singapore healthcare REIT market is segmented into private hospital real estate, nursing home and aged care facility real estate, specialist outpatient clinic buildings, and primary care medical centre assets. Private hospital real estate accounts for the dominant share of Singapore healthcare REIT market value, anchored by Parkway Life REIT's three Singapore hospitals Mount Elizabeth at Orchard, Gleneagles at Napier Road, and Parkway East at Marine Parade which collectively represent Singapore's premier private hospital campus and the highest-quality healthcare real estate in Southeast Asia.Nursing home and aged care facility real estate in Japan and France constitute Parkway Life REIT's fastest-growing portfolio segment, with the REIT's 60 nursing homes in Japan and 11 nursing homes in France generating the APAC and European revenue streams that diversify income beyond the Singapore hospital core, with nursing home acquisitions in Japan and France identified as a continuing strategic priority by Parkway Life REIT management, supported by 33% gearing that provides ample debt headroom for further acquisition per DBS Vickers analyst note.
03REIT PROFILE ANALYSIS

Two REITs Defining Singapore's Healthcare Real Estate Investment Market

PARKWAY LIFE REIT (SGX: C2PU) ASIA'S PREMIER HEALTHCARE REIT 17 CONSECUTIVE YEARS DPU GROWTH

Portfolio Value9M 2025 Distributable Income9M 2025 Gross RevenueFY2026 Singapore Rent Uplift
SGD 2.57 Billion (Sep 2025)SGD 75.4M (+10.4% YoY)SGD 117.3M (+8.2% YoY)+24.4% YoY SGD 79.7M to SGD 99.2M (AEI completion)

Parkway Life REIT, listed on the Singapore Exchange under the ticker C2PU, is one of Asia's largest listed healthcare REITs by asset size with a SGD 2.57 billion portfolio comprising three Singapore private hospitals and 71 nursing homes and care facilities across Japan and France as of September 2025. The REIT's Singapore portfolio Mount Elizabeth Hospital, Gleneagles Hospital, and Parkway East Hospital is leased under a 20.4-year master lease to Parkway Hospitals Singapore, a wholly owned subsidiary of IHH Healthcare Berhad, with the lease terms guaranteeing annual rent escalation of 2% to 3% until FY2025 and transitioning to a CPI-linked formula from FY2026, with Singapore representing 62.5% to 65% of total asset value per Q3 2025 reporting. In FY2026, aggregate rent from the Singapore hospitals is expected to increase 24.4% year-on-year from SGD 79.7 million to SGD 99.2 million following completion of the AEI at Mount Elizabeth Hospital as part of Project Renaissance, representing the most significant single-year Singapore hospital rental uplift in the REIT's history per Growbeansprout research. The REIT maintains a strong balance sheet with gearing at 35.8% and an interest coverage ratio of 8.9x, has secured a seven-year JPY loan to refinance one-third of 2026 maturities extending weighted average debt term from 2.8 to 3.2 years, and has no refinancing needs until October 2026 with 86% of interest rate exposure hedged. From 2007 to 2024, Parkway Life REIT's DPU grew approximately 136% from an annualised 6.32 cents to 14.92 cents in FY2024, maintaining 17 consecutive years of uninterrupted DPU growth.

FIRST REIT (SGX: AW9U) SOUTHEAST ASIAN DIVERSIFIED HEALTHCARE REIT

Portfolio ValueGeographic SpreadStrategyYield Profile
SGD 1.12 Billion, 32 properties15 Indonesian hospitals, Singapore, JapanIndonesia restructuring review + Japan nursing home expansionHigher yield than Parkway Life; higher risk profile

First REIT, listed on the Singapore Exchange under the ticker AW9U, owns 32 healthcare properties valued at SGD 1.12 billion spanning Indonesia, Singapore, and Japan, with 15 hospitals in Indonesia constituting the largest component of its portfolio by number and representing the primary source of geographic risk in the First REIT portfolio relative to the Singapore-anchored Parkway Life REIT model. Indonesia's private hospital real estate market, while presenting significant long-term healthcare demand growth driven by the country's 280 million population and expanding middle-income healthcare spending, carries regulatory, currency, and operational risk profiles that the IHH Healthcare triple-net lease structure at Parkway Life REIT's Singapore hospitals does not. First REIT's strategic focus on diversifying into Japan nursing homes a market with deep structural ageing demographics, high-quality regulatory oversight, and the JPY lease income that supplements the IDR-denominated Indonesian hospital income mirrors Parkway Life REIT's Japan nursing home growth strategy at a smaller scale. First REIT's higher distribution yield relative to Parkway Life REIT reflects the market's pricing of the Indonesian hospital and regulatory risk premium that distinguishes the two Singapore-listed healthcare REITs within the same asset class per ProsperUs analysis.

SINGAPORE PRIVATE HOSPITAL REAL ESTATE ANCHORS MOUNT ELIZABETH, GLENEAGLES, PARKWAY EAST
Master TenantLease TermRent EscalationOccupancy
Parkway Hospitals Singapore (IHH Healthcare subsidiary)20.4 years renewed 2021 to December 20422-3% annual until FY2025; CPI-linked from FY2026100% committed REIT bears no property tax or insurance

The three Singapore private hospitals owned by Parkway Life REIT Mount Elizabeth Hospital at Orchard, Gleneagles Hospital at Napier Road, and Parkway East Hospital at Marine Parade constitute the highest-quality healthcare real estate in Southeast Asia, collectively serving as the primary private hospital destinations for Singapore's domestic private healthcare patients, medical tourists from across ASEAN, and international patients from the Middle East and South Asia who travel to Singapore specifically for the quality and specialisation of IHH Healthcare's clinical programmes. All three hospitals enjoy 100% occupancy with Parkway Life REIT not bearing property tax or insurance costs due to the triple-net lease structure, creating a net income profile that is closest in character to the NHS-backed triple-net primary care REITs in the UK per lease structure comparison. The FY2026 rent uplift of 24.4% year-on-year from SGD 79.7 million to SGD 99.2 million following completion of the Mount Elizabeth AEI Project Renaissance expanding the hospital's diagnostic and treatment capacity demonstrates the direct linkage between Singapore private hospital capital investment and rental income growth that the REIT's master lease structure translates into DPU growth for unitholders.

MAJOR COMPANIES

Parkway Life REIT (SGX: C2PU)
Singapore
First REIT (SGX: AW9U)
Singapore
IHH Healthcare Berhad (Parkway master tenant)
Malaysia/Singapore
Parkway Hospitals Singapore Pte Ltd
Singapore
Mount Elizabeth Hospital (Orchard)
Singapore
Gleneagles Hospital (Napier Road)
Singapore
Parkway East Hospital (Marine Parade)
Singapore
Siloam Hospitals (First REIT Indonesia anchor)
Indonesia
DBS Bank Ltd (primary broker analysis)
Singapore
Monetary Authority of Singapore (REIT regulator)
Singapore
Singapore Exchange (SGX) REIT listing framework
Singapore
iPark Institute (Japan healthcare RE partner, indirectly)
Japan

STRATEGIC DEVELOPMENTS

FY2026
Parkway Life REIT, Singapore, is expected to record aggregate rent from its Singapore hospital portfolio increasing 24.4% year-on-year from SGD 79.7 million to SGD 99.2 million in FY2026, following the completion of the asset enhancement initiative at Mount Elizabeth Hospital as part of Project Renaissance, representing the most substantial single-year Singapore hospital rental uplift in the REIT's history and expected to drive close to 20% year-on-year DPU growth in FY2026 per DBS Vickers analyst note of February 2025, with AEIs also planned at Gleneagles Hospital and Parkway East Hospital providing further rental uplift potential, and the acquisition of Mount Elizabeth Novena remaining opportunistic per DBS Vickers analyst guidance.
9M 2025
Parkway Life REIT, Singapore, reported 9M 2025 gross revenue of SGD 117.3 million, up 8.2% year-on-year, driven by contributions from newly acquired nursing homes in Japan and France alongside marginal appreciation of the Japanese yen, with distributable income of SGD 75.4 million up 10.4% year-on-year and a 9M 2025 DPU of 11.56 cents translating to an annualised distribution yield of 3.8% at the prevailing unit price, with gearing at 35.8% and an interest coverage ratio of 8.9x, and the REIT securing a seven-year JPY loan to refinance one-third of its 2026 maturities, extending the weighted average debt term from 2.8 to 3.2 years with no refinancing needs until October 2026 per Growbeansprout analysis of November 2025.
FY2024
Parkway Life REIT, Singapore, reported FY2024 distribution per unit of SGD 0.1492, up 1% year-on-year, marking 17 consecutive years of DPU growth since its 2007 IPO, reflecting DPU growth of approximately 136% from the annualised DPU of 6.32 cents at listing to 14.92 cents in FY2024, with the SGD 2.57 billion portfolio comprising three Singapore hospitals and 71 nursing homes and care facilities across Japan and France delivering resilient income against a backdrop of Japanese yen weakness that partially offset the Japan segment revenue growth, while Singapore accounted for 62.5% to 65% of asset value under the 20.4-year master lease to December 2042 per Growbeansprout initiation research of April 2025 and Parkway Life REIT annual results.
2024
Parkway Life REIT, Singapore, completed its first equity fund raising exercise in its history to acquire 11 nursing home properties in France, with the acquisition approximately 2% accretive to DPU and approximately 4% accretive to NAV per unit despite full equity financing, adding 11 French nursing homes to complement the existing 60 Japanese nursing home and care facilities in the portfolio and demonstrating the REIT's ability to expand into European aged care real estate as a diversification strategy beyond its Singapore and Japan core, per Growbeansprout research and Parkway Life REIT company disclosures.
2021
Parkway Life REIT, Singapore, renewed the master lease for its three Singapore private hospitals Mount Elizabeth, Gleneagles, and Parkway East for a 20.4-year term ending December 2042, with an option to renew for a further term of 10 years, the renewal structured with guaranteed annual rent escalation of 2% to 3% until FY2025 and a CPI-linked formula from FY2026, with 100% committed occupancy and a triple-net lease structure under which the REIT bears no property tax or insurance costs, securing the income base of the Singapore healthcare REIT market's anchor asset class for the period to at minimum December 2052 per Parkway Life REIT investor disclosure and DBS Vickers analyst note.

Ordered 2026 first. All developments sourced from Parkway Life REIT and First REIT investor disclosures, DBS Vickers analysis, Growbeansprout research, and verified trade press.

KEY QUESTIONS ANSWERED

01
What is the total size of the Singapore healthcare REIT market in 2025 and what value is projected by 2035 at the forecast CAGR of 7.8%?
02
With FY2026 aggregate rent from Parkway Life REIT's Singapore hospital portfolio expected to increase 24.4% year-on-year from SGD 79.7 million to SGD 99.2 million following the Mount Elizabeth AEI completion and DPU expected to grow close to 20% in FY2026 per DBS Vickers how does this contractually guaranteed rental uplift compare in risk profile and income visibility to the operational SHOP NOI growth being generated by Welltower and Ventas in the US senior housing market?
03
How does the combination of Parkway Life REIT's 20.4-year master lease to December 2042 with IHH Healthcare subsidiary Parkway Hospitals Singapore, guaranteed rent escalation, triple-net lease structure, 100% committed occupancy, and 17 consecutive years of DPU growth create an income security profile that is structurally comparable to NHS-backed primary care REITs in the UK and at what valuation multiple does the market currently price this income security?
04
How is Parkway Life REIT managing its Japanese yen and euro currency risk with approximately 27% of earnings from Japan and 8% from France through its strategy of JPY-denominated loan financing and the seven-year JPY loan that refinanced one-third of 2026 maturities, and what residual currency risk remains after hedging at the REIT's current Japan and France portfolio weighting?
05
How does First REIT's Indonesia hospital portfolio 15 hospitals comprising the majority of its SGD 1.12 billion portfolio present a different risk-return profile from Parkway Life REIT's Singapore hospital core, and what is the strategic rationale for First REIT's Japan nursing home expansion as a portfolio quality and income stability enhancement strategy against the backdrop of Indonesia healthcare real estate regulatory risk?
06
What is the total addressable Singapore healthcare REIT market opportunity from the potential acquisition of Mount Elizabeth Novena Hospital identified by DBS Vickers as an opportunistic target for Parkway Life REIT and how does Parkway Life REIT's 33% gearing with ample debt headroom position it to pursue this acquisition alongside the planned AEIs at Gleneagles and Parkway East hospitals?

TABLE OF CONTENTS

01
Singapore Healthcare REIT Market Overview and Country Scope
02
Market Size, Growth, and Forecast 2025 to 2035
03
Market Drivers IHH Tenant Strength, FY2026 Rent Uplift, Japan Nursing Home Expansion
04
Market Restraints Currency Risk (JPY/EUR), LNG Energy Cost, Concentration Risk
05
Segment Analysis By REIT and By Property Type
06
REIT Profile Parkway Life REIT (17yr DPU Growth, SGD 2.57B, Mount Elizabeth AEI)
07
REIT Profile First REIT (SGD 1.12B, Indonesia Hospitals, Japan Expansion)
08
Singapore Private Hospital Real Estate IHH Master Lease, Triple-Net Structure, AEI Pipeline
09
Japan Nursing Home Portfolio 60 Properties, JPY Loan Strategy, Acquisition Pipeline
10
France Nursing Home Portfolio 11 Properties, European Healthcare RE Expansion
11
Capital Market Analysis SGX S-REIT Framework, DPU Yield, P/B Valuation, Gearing
12
Comparison to Global Healthcare REIT Peers Welltower, Ventas, PHP, UK Primary Care
13
Competitive Landscape Parkway Life REIT, First REIT, IHH Healthcare, DBS Analysis
14
Strategic Developments and Investment Activity